Literature DB >> 24667139

MUC1: a multifaceted oncoprotein with a key role in cancer progression.

Sritama Nath1, Pinku Mukherjee2.   

Abstract

The transmembrane glycoprotein Mucin 1 (MUC1) is aberrantly glycosylated and overexpressed in a variety of epithelial cancers, and plays a crucial role in progression of the disease. Tumor-associated MUC1 differs from the MUC1 expressed in normal cells with regard to its biochemical features, cellular distribution, and function. In cancer cells, MUC1 participates in intracellular signal transduction pathways and regulates the expression of its target genes at both the transcriptional and post-transcriptional levels. This review highlights the structural and functional differences that exist between normal and tumor-associated MUC1. We also discuss the recent advances made in the use of MUC1 as a biomarker and therapeutic target for cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ABC pumps; EMT; Mucin 1 (MUC1); VNTR; cancer; cancer stem cell

Mesh:

Substances:

Year:  2014        PMID: 24667139      PMCID: PMC5500204          DOI: 10.1016/j.molmed.2014.02.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  116 in total

Review 1.  MUC1 immunotherapy.

Authors:  Richard E Beatson; Joyce Taylor-Papadimitriou; Joy M Burchell
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

2.  Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases.

Authors:  B Mann; E Klussmann; V Vandamme-Feldhaus; M Iwersen; M L Hanski; E O Riecken; H J Buhr; R Schauer; Y S Kim; C Hanski
Journal:  Int J Cancer       Date:  1997-07-17       Impact factor: 7.396

3.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.

Authors:  H Kashiwagi; H Kijima; S Dowaki; Y Ohtani; K Tobita; M Tsukui; Y Tanaka; H Matsubayasi; T Tsuchida; H Yamazaki; M Nakamura; Y Ueyama; M Tanaka; T Tajima; H Makuuchi
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

4.  Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways.

Authors:  Eric J Thompson; Kandavel Shanmugam; Christine L Hattrup; Kari L Kotlarczyk; Albert Gutierrez; Judy M Bradley; Pinku Mukherjee; Sandra J Gendler
Journal:  Mol Cancer Res       Date:  2006-07       Impact factor: 5.852

5.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

6.  MUC1 is a substrate for gamma-secretase.

Authors:  Joanne Julian; Neeraja Dharmaraj; Daniel D Carson
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

7.  MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.

Authors:  Norishige Yamada; Yukari Nishida; Hideaki Tsutsumida; Tomofumi Hamada; Masamichi Goto; Michiyo Higashi; Mitsuharu Nomoto; Suguru Yonezawa
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

9.  MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state.

Authors:  Benoit J Smagghe; Andrew K Stewart; Mark G Carter; Laura M Shelton; Kyle J Bernier; Eric J Hartman; Amy K Calhoun; Vasilios M Hatziioannou; Gabriele Lillacci; Brian A Kirk; Brian A DiNardo; Kenneth S Kosik; Cynthia Bamdad
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  234 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 2.  Genetics and gastric cancer susceptibility.

Authors:  Yan Lu; Fang Lu; Sha Zeng; Suqing Sun; Li Lu; Lifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

Review 4.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

Review 5.  B cells, plasma cells and antibody repertoires in the tumour microenvironment.

Authors:  George V Sharonov; Ekaterina O Serebrovskaya; Diana V Yuzhakova; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Rev Immunol       Date:  2020-01-27       Impact factor: 53.106

Review 6.  How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Authors:  H Lincet; P Icard
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 7.  Improving theranostics in pancreatic cancer.

Authors:  Jeremy King; Michael Bouvet; Gagandeep Singh; John Williams
Journal:  J Surg Oncol       Date:  2017-05-17       Impact factor: 3.454

8.  Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.

Authors:  Asaf Madi; Sharron Bransburg-Zabary; Ayala Maayan-Metzger; Gittit Dar; Eshel Ben-Jacob; Irun R Cohen
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.

Authors:  Camille Jacqueline; Amanda Lee; Nolan Frey; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2020-05-28       Impact factor: 11.151

10.  Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models.

Authors:  S Masoumi-Moghaddam; A Amini; D L Morris
Journal:  Clin Transl Oncol       Date:  2016-05-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.